Navigation Links
NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again
Date:5/5/2010

Unreliable lie detector readings result in innocent man spending 22 years in prison for murder; guilty man kills again.

Rochester, NY (PRWEB) May 5, 2010 -- National Association of Computer Voice Stress Analysts says it’s past time to reevaluate the polygraph’s role in criminal investigations. A recent WHEC.com story concerns what can only be described as one of the worst failures of the polygraph, a killer passed and an innocent man failed the polygraph during the murder investigation of 74-year-old Viola Manville in 1988. After failing the polygraph administered by the New York State Police, detectives were able to get the innocent man, Frank Sterling, to confess to the murder. Sterling was then convicted of Manville’s murder and sent to prison while her actual killer, Mark Christie, who passed the polygraph, also conducted by the New York State Police, went on to abduct and murder four-year-old Kali Ann Poulton. Christie was convicted of her murder and recently confessed to Manville’s murder. Frank Sterling was released from prison last week. If the polygraph had accurately identified Christie as the killer, little Kali Ann Poulton would still be alive and Frank Sterling would not have spent 22 years in prison for a crime that he did not commit.

This horrific case follows on the heels of the March 23, 2010 case where the murder of five Newark, NJ, teens in 1978 was solved by the recent confession of one of the killers, Lee Anthony Evans. Evans was the main suspect at the time of the initial investigation and took at least one polygraph test, which he passed. With no leads a
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NACVSA: Killer of Five Teenagers Passes Polygraph
2. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
3. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
4. DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger
5. NeoStem Appoints Deloitte & Touche as New Independent Registered Public Accounting Firm
6. ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
7. Spectral appoints two new board members
8. IGEN Networks appoints directors and provides business update
9. Enerkem appoints new Chief Financial Officer
10. Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development
11. Glycos Biotechnologies Appoints Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/29/2015)... , July 30, 2015 ... santé, publie ses résultats pour le premier semestre ... commente les résultats. Visionner l,interview vidéo ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de l,interview ... - Moteurs de croissance - Diabète ...
(Date:7/29/2015)... 2015  HealthSouth Corporation (NYSE: HLS ... post-acute healthcare services, offering both facility-based and home-based ... for the second quarter ended June 30, 2015. ... strong volume growth in both segments and an ... Grinney, President and Chief Executive Officer of HealthSouth. ...
(Date:7/29/2015)... Inc., an early stage biotech startup based on perinatal ... the Musculoskeletal Transplant Foundation of Edison NJ ... round of development of the proprietary AmnioCept™ product line ... AmnioChor,s technology allows cryopreservation of the amniotic membrane of ... those tissues. Amnion is a well-established source of multipotent ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17
... ANDS ) today announced that patient dosing has ... oral TLR7 agonist prodrug, in,patients with advanced solid tumors. ... to identify pharmacologically active doses,and preliminary antitumor activity as ... II trials., The Phase I trial is a ...
... Co., Ltd. (President:,Dr. Yuzuru Matsuda) announced that Kyowa ... U.S. subsidiary, received on February 25,2008 (local time) ... and Drug,Administration (FDA) for istradefylline (KW-6002), its investigational ... the not approvable letter FDA expressed concern if ...
... at North Carolina State University have demonstrated that ... chemically different so-called Janus particles will ... field is applied to liquid surrounding the particles. ... the Feb. 8, 2008, edition of Physical Review ...
Cached Biology Technology:Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 2Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 3Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 4Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002) 2'2-faced' particles act like tiny submarines 2
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... CITY , Jan. 24, 2013 /PRNewswire-iReach/ -- Amiigo, ... has developed a new device for gesture recognition and ... that uses accelerometers and machine learning algorithms to automatically ... device knows if users are using the elliptical trainer ...
... than geologists previously thought, according to new research results. ... put very small samples of peridotite, rock derived from Earth,s ... found that the rock can and does liquify, at least ... deep as 250 kilometers down in the mantle beneath the ...
... leading experts will meet today in Brussels, Belgium, to ... research and the key findings of FLAVIOLA an ... health benefits and potential applications. Members of the FLAVIOLA ... researchers to review the outcomes of FLAVIOLA,s research and ...
Cached Biology News:Amiigo Unveils Fitness Tracker That Knows What Exercise You're Performing 2Magma in Earth's mantle forms deeper than once thought 2Magma in Earth's mantle forms deeper than once thought 3Recent breakthroughs in cocoa flavanol research discussed by European research consortium and expert panel 2